Symbols / PMI $1.19 -6.30%
PMI Chart
About
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 87.70M |
| Enterprise Value | 91.40M | Income | -32.22M | Sales | 4.77M |
| Book/sh | 0.11 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | 75 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 18.40 | P/B | 11.02 | P/C | — |
| EV/EBITDA | -6.69 | EV/Sales | 19.17 | Quick Ratio | 0.71 |
| Current Ratio | 2.16 | Debt/Eq | 7.73 | LT Debt/Eq | — |
| EPS (ttm) | -0.44 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 34.70% | Earnings | 2026-03-31 | ROA | -67.32% |
| ROE | — | ROIC | — | Gross Margin | -10.05% |
| Oper. Margin | -293.77% | Profit Margin | 0.00% | Shs Outstand | 73.70M |
| Shs Float | 26.14M | Short Float | 1.03% | Short Ratio | 0.38 |
| Short Interest | — | 52W High | 13.68 | 52W Low | 0.96 |
| Beta | — | Avg Volume | 826.71K | Volume | 112.63K |
| Target Price | — | Recom | None | Prev Close | $1.27 |
| Price | $1.19 | Change | -6.30% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.20
Latest analyst target
3. DCF / Fair value
$-2.62
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.20
Low
—
High
—
Mean
—
News
RSS: Latest PMI news- A 29-year-old lived over four years on an artificial heart, then got a transplant - Stock Titan ue, 17 Mar 2026 11
- Picard Medical Shareholders Approve Expanded Capital Stock Authorization - TipRanks Mon, 16 Mar 2026 20
- Picard Medical shareholders approve share increase and stock issuance proposals - Investing.com Mon, 16 Mar 2026 20
- Picard Medical (PMI): Assessing Valuation After Share Expansion and Dilution Concerns Spark Sell-Off - Yahoo Finance Sat, 25 Oct 2025 07
- Picard Medical (PMI): Valuation Reassessed After Equity Plan Sparks Dilution Concerns and Stock Drop - simplywall.st Sat, 25 Oct 2025 07
- 2 No-Brainer Dividend Stocks to Buy Right Now - The Motley Fool ue, 03 Mar 2026 08
- Artificial heart supports patients awaiting transplants, now on FOX Business - Stock Titan Fri, 13 Mar 2026 10
- Bragar Eagel & Squire Urges Picard Medical Investors to Contact Firm Before April 3rd - National Today Mon, 16 Mar 2026 05
- Bragar Eagel & Squire, P.C. Urges Picard Medical, Inc. (NYSE:PMI) Investors to Contact the Firm Before April 3rd Regarding Their Rights - marketscreener.com Sun, 15 Mar 2026 22
- Premier Miton Group (LON:PMI) Stock Price Up 3.2% - Time to Buy? - MarketBeat Fri, 27 Feb 2026 08
- Picard Medical Highlights Long-Term Total Artificial Heart Success - TipRanks ue, 17 Mar 2026 11
- New artificial heart design targets mobility and quality of life gains - Stock Titan Mon, 02 Mar 2026 08
- Picard (NYSE American: PMI) not aware of undisclosed material change amid volatility - Stock Titan Fri, 24 Oct 2025 07
- PMI - Picard Medical, Inc. Latest Stock News & Market Updates - Stock Titan Sun, 22 Feb 2026 13
- Picard Medical (PMI) CEO to present Emperor TAH data at CSI Focus D-HF - Stock Titan Wed, 03 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | -3.05K | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.21 |
| NormalizedEBITDA | -13.17M | -14.85M | -10.61M |
| TotalUnusualItems | -4.29M | ||
| TotalUnusualItemsExcludingGoodwill | -4.29M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -21.05M | -15.57M | -11.17M |
| ReconciledDepreciation | 543.00K | 585.00K | 545.00K |
| ReconciledCostOfRevenue | 4.50M | 7.35M | 9.10M |
| EBITDA | -17.46M | -14.85M | -10.61M |
| EBIT | -18.00M | -15.43M | -11.15M |
| NetInterestIncome | -3.07M | -138.00K | 4.00K |
| InterestExpense | 3.07M | 140.00K | 5.00K |
| InterestIncome | 0.00 | 2.00K | 9.00K |
| NormalizedIncome | -16.77M | -15.57M | -11.17M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -21.05M | -15.57M | -11.17M |
| TotalExpenses | 18.10M | 20.55M | 15.18M |
| RentExpenseSupplemental | 2.01M | 2.41M | 1.43M |
| TotalOperatingIncomeAsReported | -13.71M | -15.50M | -11.07M |
| DilutedAverageShares | 72.06M | 72.06M | 72.06M |
| BasicAverageShares | 72.06M | 72.06M | 72.06M |
| DilutedEPS | -0.33 | -0.25 | -0.18 |
| BasicEPS | -0.33 | -0.25 | -0.18 |
| DilutedNIAvailtoComStockholders | -23.74M | -18.00M | -12.67M |
| NetIncomeCommonStockholders | -23.74M | -18.00M | -12.67M |
| PreferredStockDividends | 2.68M | 2.43M | 1.50M |
| NetIncome | -21.05M | -15.57M | -11.17M |
| NetIncomeIncludingNoncontrollingInterests | -21.05M | -15.57M | -11.17M |
| NetIncomeContinuousOperations | -21.05M | -15.57M | -11.17M |
| TaxProvision | -15.00K | -2.00K | 11.00K |
| PretaxIncome | -21.07M | -15.57M | -11.16M |
| OtherIncomeExpense | -4.29M | 69.00K | -94.00K |
| OtherNonOperatingIncomeExpenses | 69.00K | -94.00K | |
| GainOnSaleOfSecurity | -4.29M | ||
| NetNonOperatingInterestIncomeExpense | -3.07M | -138.00K | 4.00K |
| InterestExpenseNonOperating | 3.07M | 140.00K | 5.00K |
| InterestIncomeNonOperating | 0.00 | 2.00K | 9.00K |
| OperatingIncome | -13.71M | -15.50M | -11.07M |
| OperatingExpense | 13.60M | 13.19M | 6.08M |
| ResearchAndDevelopment | 3.38M | 2.21M | 1.90M |
| SellingGeneralAndAdministration | 10.22M | 10.98M | 4.18M |
| GrossProfit | -112.00K | -2.31M | -4.99M |
| CostOfRevenue | 4.50M | 7.35M | 9.10M |
| TotalRevenue | 4.39M | 5.04M | 4.11M |
| OperatingRevenue | 4.39M | 5.04M | 4.11M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| OrdinarySharesNumber | 72.06M | 72.06M | 72.06M |
| ShareIssued | 72.06M | 72.06M | 72.06M |
| NetDebt | 19.88M | 8.10M | 468.00K |
| TotalDebt | 20.93M | 9.41M | 1.96M |
| TangibleBookValue | -45.21M | -25.12M | -10.28M |
| InvestedCapital | -24.02M | -15.48M | -8.28M |
| WorkingCapital | -25.53M | -451.00K | 9.12M |
| NetTangibleAssets | -24.95M | -4.85M | 9.98M |
| CapitalLeaseObligations | 951.00K | 1.07M | 1.34M |
| CommonStockEquity | -44.00M | -23.82M | -8.90M |
| PreferredStockEquity | 20.27M | 20.27M | 20.27M |
| TotalCapitalization | -23.74M | 730.00K | 11.37M |
| TotalEquityGrossMinorityInterest | -23.74M | -3.55M | 11.37M |
| StockholdersEquity | -23.74M | -3.55M | 11.37M |
| GainsLossesNotAffectingRetainedEarnings | 278.00K | 293.00K | 398.00K |
| OtherEquityAdjustments | 278.00K | 293.00K | 398.00K |
| RetainedEarnings | -49.84M | -28.79M | -13.22M |
| AdditionalPaidInCapital | 5.56M | 4.67M | 3.92M |
| CapitalStock | 20.27M | 20.27M | 20.27M |
| CommonStock | 1.00K | 1.00K | 0.00 |
| PreferredStock | 20.27M | 20.27M | 20.27M |
| TotalLiabilitiesNetMinorityInterest | 35.84M | 14.93M | 4.07M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 517.00K | 5.71M | 1.07M |
| OtherNonCurrentLiabilities | 670.00K | ||
| PreferredSecuritiesOutsideStockEquity | 20.27M | 20.27M | 20.27M |
| NonCurrentAccruedExpenses | 0.00 | 670.00K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 517.00K | 5.04M | 1.07M |
| LongTermCapitalLeaseObligation | 517.00K | 762.00K | 1.07M |
| LongTermDebt | 4.28M | ||
| CurrentLiabilities | 35.33M | 9.21M | 3.00M |
| OtherCurrentLiabilities | 6.76M | 64.00K | 25.00K |
| CurrentDebtAndCapitalLeaseObligation | 20.41M | 4.37M | 887.00K |
| CurrentCapitalLeaseObligation | 434.00K | 310.00K | 267.00K |
| CurrentDebt | 19.98M | 4.06M | 620.00K |
| OtherCurrentBorrowings | 19.98M | 4.06M | 620.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 941.00K | 770.00K | 248.00K |
| PayablesAndAccruedExpenses | 7.21M | 4.08M | 1.86M |
| CurrentAccruedExpenses | 1.92M | 992.00K | 472.00K |
| InterestPayable | 761.00K | 0.00 | |
| Payables | 5.29M | 3.08M | 1.39M |
| AccountsPayable | 5.29M | 3.08M | 1.39M |
| TotalAssets | 12.11M | 11.37M | 15.44M |
| TotalNonCurrentAssets | 2.31M | 2.61M | 3.32M |
| GoodwillAndOtherIntangibleAssets | 1.21M | 1.30M | 1.39M |
| OtherIntangibleAssets | 596.00K | 684.00K | 771.00K |
| Goodwill | 615.00K | 615.00K | 615.00K |
| NetPPE | 1.10M | 1.31M | 1.93M |
| AccumulatedDepreciation | -523.00K | -459.00K | -293.00K |
| GrossPPE | 1.63M | 1.77M | 2.22M |
| Leases | 101.00K | 101.00K | 101.00K |
| OtherProperties | 643.00K | 717.00K | 898.00K |
| MachineryFurnitureEquipment | 883.00K | 955.00K | 1.23M |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 9.79M | 8.76M | 12.12M |
| OtherCurrentAssets | 955.00K | 883.00K | 1.00M |
| Inventory | 8.12M | 6.89M | 7.33M |
| InventoriesAdjustmentsAllowances | -2.41M | -2.19M | -1.72M |
| FinishedGoods | 1.44M | 1.70M | 2.44M |
| WorkInProcess | 2.76M | 1.09M | 1.29M |
| RawMaterials | 6.32M | 6.29M | 5.32M |
| Receivables | 625.00K | 741.00K | 3.64M |
| DuefromRelatedPartiesCurrent | 112.00K | 112.00K | 2.76M |
| AccountsReceivable | 513.00K | 629.00K | 882.00K |
| CashCashEquivalentsAndShortTermInvestments | 96.00K | 244.00K | 152.00K |
| CashAndCashEquivalents | 96.00K | 244.00K | 152.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| FreeCashFlow | -11.87M | -10.64M | -10.75M |
| RepaymentOfDebt | -1.38M | -890.00K | -26.00K |
| IssuanceOfDebt | 13.12M | 9.08M | 5.55M |
| IssuanceOfCapitalStock | 0.00 | 2.65M | 0.00 |
| CapitalExpenditure | -7.00K | -29.00K | |
| InterestPaidSupplementalData | 1.00K | 1.00K | 2.00K |
| IncomeTaxPaidSupplementalData | 0.00 | 1.00K | 2.00K |
| EndCashPosition | 96.00K | 244.00K | 152.00K |
| BeginningCashPosition | 244.00K | 152.00K | 5.25M |
| EffectOfExchangeRateChanges | -15.00K | -105.00K | 134.00K |
| ChangesInCash | -133.00K | 197.00K | -5.24M |
| FinancingCashFlow | 11.74M | 10.84M | 5.52M |
| CashFlowFromContinuingFinancingActivities | 11.74M | 10.84M | 5.52M |
| NetPreferredStockIssuance | 0.00 | 2.65M | 0.00 |
| PreferredStockIssuance | 0.00 | 2.65M | 0.00 |
| NetIssuancePaymentsOfDebt | 11.74M | 8.19M | 5.52M |
| NetShortTermDebtIssuance | 8.10M | 4.04M | 0.00 |
| ShortTermDebtPayments | -1.32M | -880.00K | 0.00 |
| ShortTermDebtIssuance | 9.42M | 4.92M | 0.00 |
| NetLongTermDebtIssuance | 3.64M | 4.15M | 5.52M |
| LongTermDebtPayments | -56.00K | -10.00K | -26.00K |
| LongTermDebtIssuance | 3.70M | 4.16M | 5.55M |
| InvestingCashFlow | 0.00 | -9.00K | -37.00K |
| CashFlowFromContinuingInvestingActivities | 0.00 | -9.00K | -37.00K |
| NetOtherInvestingChanges | -2.00K | -8.00K | |
| NetPPEPurchaseAndSale | 0.00 | -7.00K | -29.00K |
| PurchaseOfPPE | 0.00 | -7.00K | -29.00K |
| OperatingCashFlow | -11.87M | -10.63M | -10.72M |
| CashFlowFromContinuingOperatingActivities | -11.88M | -10.63M | -10.72M |
| ChangeInWorkingCapital | 963.00K | 3.28M | -1.93M |
| ChangeInOtherCurrentLiabilities | -311.00K | 0.00 | |
| ChangeInPayablesAndAccruedExpense | 2.56M | 3.35M | -155.00K |
| ChangeInAccruedExpense | 350.00K | 1.75M | -262.00K |
| ChangeInPayable | 2.21M | 1.61M | 107.00K |
| ChangeInAccountPayable | 2.21M | 1.61M | 107.00K |
| ChangeInPrepaidAssets | -72.00K | 120.00K | -390.00K |
| ChangeInInventory | -1.33M | -446.00K | -1.59M |
| ChangeInReceivables | 116.00K | 253.00K | 210.00K |
| ChangesInAccountReceivables | 116.00K | 253.00K | 210.00K |
| OtherNonCashItems | 2.39M | ||
| StockBasedCompensation | 886.00K | 133.00K | 148.00K |
| ProvisionandWriteOffofAssets | 108.00K | 879.00K | 1.68M |
| DepreciationAmortizationDepletion | 543.00K | 585.00K | 545.00K |
| DepreciationAndAmortization | 543.00K | 585.00K | 545.00K |
| AmortizationCashFlow | 87.00K | ||
| AmortizationOfIntangibles | 87.00K | ||
| Depreciation | 456.00K | 585.00K | 545.00K |
| OperatingGainsLosses | 4.29M | 58.00K | |
| GainLossOnInvestmentSecurities | 4.29M | ||
| GainLossOnSaleOfPPE | 0.00 | 58.00K | 0.00 |
| NetIncomeFromContinuingOperations | -21.05M | -15.57M | -11.17M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for PMI
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|